[EN] PYRROLIDINE-SUBSTITUTED AZAINDOLE COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY<br/>[FR] COMPOSÉS AZA-INDOLE SUBSTITUÉ PAR UN RÉSIDU PYRROLIDINE AYANT UNE AFFINITÉ POUR LE RÉCEPTEUR 5-HT6
申请人:MEMORY PHARM CORP
公开号:WO2010002802A1
公开(公告)日:2010-01-07
The present disclosure provides compounds having affinity for the 5-HTg receptor which are of the formula (I): wherein R1, R2, A, B, D, E, G, Ar, and n are as defined herein. The disclosure also relates to methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.
PYRROLIDINE-SUBSTITUTED AZAINDOLE COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY
申请人:Danca Mihaela Diana
公开号:US20100022581A1
公开(公告)日:2010-01-28
The present disclosure provides compounds having affinity for the 5-HT
6
receptor which are of the formula (I):
wherein R
1
, R
2
, A, B, D, E, G, Ar, and n are as defined herein. The disclosure also relates to methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.
Stereodefined oligonucleoside H‐phosphonates were synthesized on a solid support using diastereopure nucleoside 3′‐O‐oxazaphospholidine monomers. Several stereodefined backbone‐modified analogues were obtained with the oligonucleoside H‐phosphonates as precursors (see scheme; BPRO=protected nucleobase, DMTr=4,4′‐dimethoxytrityl, Th=thymin‐1‐yl, TfO−=triflate).